The inhibition of IP6K using SC-919 to suppress cellular phosphate export has therapeutic relevance, as we found that IP6K inhibition alleviated hyperphosphataemia and improved kidney function parameters. The gene discussed is PPIP5K1; the disease is hyperphosphatemia.